Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy.

Autor: Ferreira NN; School of Pharmaceutical Science, São Paulo State University, UNESP, Rodovia Araraquara/Jaú km 1, Araraquara, São Paulo, Brazil., M B Ferreira L; School of Pharmaceutical Science, São Paulo State University, UNESP, Rodovia Araraquara/Jaú km 1, Araraquara, São Paulo, Brazil., Miranda-Gonçalves V; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal., Reis RM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil., Seraphim TV; Institute of Chemistry of São Carlos, University of São Paulo, USP, São Carlos, Brazil., Borges JC; Institute of Chemistry of São Carlos, University of São Paulo, USP, São Carlos, Brazil., Baltazar F; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal., Gremião MPD; School of Pharmaceutical Science, São Paulo State University, UNESP, Rodovia Araraquara/Jaú km 1, Araraquara, São Paulo, Brazil. Electronic address: pgremiao@fcfar.unesp.br.

Publikováno v: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2017 Oct; Vol. 119, pp. 271-282. Date of Electronic Publication: 2017 Jun 29.